Trial
NCT04832139
A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
—
Condition
Healthy Volunteers
Intervention
Marstacimab PFP
Why stopped
The study was terminated due to a change in the benefit/risk assessment for the further administration of marstacimab in a healthy volunteer population.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-11